Hematology. Transfusiology. Eastern Europe
2016, volume 2, №1
The electronic edition – Free
Print version
In this issue:
Organization of hematologic care
Steps of organizing a National register of donor hematopoietic stem cells in the Republic of Belarus
Molecular genetic characteristics of primary immunodeficiency in Ukraine
Original research. Scientific publication
A comparative analysis of Free Light Chain concentrations in serum and cerebrospinal fluid for patients with multiple myeloma complicated by myeloradiculopathy
Expression of CD25 on blast cells as unfavorable prognostic factors in patients with acute myeloid leukemia of adults
The complex biochemical study of the content of biogenic amines and heparin in blood plasma in patients with acute leucosis during intensive chemotherapy
Free heparin blood plasma of patients with polycythemia vera and incidence of neurological cerebral symptoms
Morphological description of buccal epithelium at normal and oncological pathologies in human organism
Reviews. Lectures
Modern principles of infusion-transfusion therapy in polytrauma blood loss and massive transfusion protocol
Тhe types of modern seminars in medical post-graduate education
Complications and side effects when applying preparations of iron salts
Obinutuzumab (GA101) for the Treatment of Chronic Lymphocytic Leukemia and Other B-Cell Non-Hodgkin’s Lymphomas: A Glycoengineered Type II CD20 Antibody
FDA approves Roche’s Gazyva (obinutuzumab) for certain people with previously treated follicular lymphoma
Practice
Chronic myeloid leukemia in children of Belarus: analysis of Imatinib treatment efficacy
The effectiveness of substitution therapy with immunoglobulin preparations for subcutaneous administration in children with primary immunodeficiencies
Clinical manifestations and treatment features of non-Hodgkin’s lymphomas in children with chromosomal instability syndromes
Acute megakaryoblastic leukemia megakaryoblastic cells
Proceedings of the conference
Analysis of Tp53 gene polymorphic variants in predicting of toxic complications in non-Hodgkin’s lymphoma treatment
On the prevention of iron states in infants
Prognostic value of immunohistochemical expression of Bcl-6 in Diffuse large B-cell lymphoma patients
The effectiveness of second line treatment of relapse and primary refractory non-Hodgkins and Hodgkins lymphomas
BCL-2 and BCL-6 expression in Diffuse large B-cell lymphoma in patients from high-risk group